Oh Y, Jung HR, Min S, Kang J, et al. Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers. Cancer Lett 2021;497:123-136.
PMID: 33068701